|
KMID : 0387420060170010059
|
|
Korean Society of Oriental Neuropsychiatry
2006 Volume.17 No. 1 p.59 ~ p.78
|
|
|
The Effects of ChongMyungTang(CMT) and SanSaChongMyungTang(SCMT) on the Alzheimer’s Disease Model
|
|
Ha Su-Young
Jung In-Chul
Lee Sang-Ryong
|
|
|
Abstract
|
|
|
Objective:This research investigates the effect of the CMT and SCMT on Alzheimer’s disease.
Methods:The effects of the CMT and SCMT on (1) amyloid precursor proteins(APP), acetylcholinesterase(AChE) mRNA of PC-12 cells treated with CT-105; (2) the AChE activity and the APP production of PC-12 cell treated with CT-105; (3) the behavior; (4) expression of $IL-1{\beta}$, $TNF-{\alpha}$, MDA; (5) the infarction area of the hippocampus in Alzheimer’s disease mice induced with CT105 & ${\beta}A$ were investigated
Results:1. The CMT and SCMT suppressed the expression of APP, AChE mRNA in PC-12 cells treated with CT-105 2. The CMT and SCMT suppressed the AChE activity, and the production of APP significantly in PC-12 cells treated with CT-105. 3. For the CMT and SCMT group a significant inhibitory effect on the memory deficit was shown for the mice with Alzheimer’s disease induced by ${\beta}A$ in the Morris water maze experiment, which measured stop-through latency, and distance movement-through latency 4. The CMT and SCMT suppressed the over-expression of $IL-1{\beta}$, $TNF-{\alpha}$, MDA in the mice with Alzheimer’s disease induced by ${\beta}A$. 5. The CMT and SCMT reduced the infarction area of hippocampus with Alzheimer’s disease induced by ${\beta}A$.
Conclusion: These results suggest that the CMT and SCMT may be effective for the prevention and treatment of Alzheimer’s disease. Investigation into the clinical use of the CMT and SCMT for Alzheimer’s disease is suggested for future research.
|
|
|
KEYWORD
|
|
|
ChongMyungTang(CMT), SanSaChongMyungTang(SCMT), Alzheimer’s Disease
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|